Rohin Patel

Stock Analyst at JP Morgan

(2.21)

# 3,570

Out of 5,182 analysts

5

Total ratings

66.67%

Success rate

12.31%

Average return

Main Sectors:

Top Industries:

Medical Devices

Stocks Rated by Rohin Patel

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	HAE Haemonetics	Maintains: Neutral	$62 → $74	$55.32	+33.77%	3	Dec 12, 2025
	NPCE NeuroPace	Maintains: Overweight	$18 → $20	$16.90	+18.34%	2	Dec 10, 2025

Haemonetics

Dec 12, 2025

Maintains: Neutral

Price Target: $62 → $74

Current: $55.32

Upside: +33.77%

NeuroPace

Dec 10, 2025

Maintains: Overweight

Price Target: $18 → $20

Current: $16.90

Upside: +18.34%